Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Carbone

Showing results (461-470 of 651) with videos related to

Pageof 66
Sort By:
Cancer Research Communications|October 18, 2023
Exogenous Sequences in Tumors and Immune Cells (Exotic): A Tool for Estimating the Microbe Abundances in Tumor RNA-seq DataRebecca Hoyd, Caroline E Wheeler, YunZhou Liu, et al.
The Journal of Clinical Investigation|March 6, 2003
Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptorLi Yang, Noboru Yamagata, Rajwardhan Yadav, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Phase I study of Paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced non-small cell lung cancerDavid I Rosenthal, Clifton David Fuller, Mitchell Machtay, et al.
The Journal of Clinical Investigation|December 18, 2025
PPP2R2A insufficiency enhances PD-L1 immune checkpoint blockade efficacy in lung cancer through cGAS-STING activationZhaojun Qiu, No-Joon Song, Anqi Li, et al.
Annals of Internal Medicine|May 1, 1980
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer InstituteV T DeVita, R M Simon, S M Hubbard, et al.
JTO Clinical and Research Reports|April 18, 2025
Trends in Mesothelioma Mortality in the United States Between 1999 and 2020Alexander J Didier, Mingjia Li, Jinesh Gheeya, et al.
International Journal of Immunopathology and Pharmacology|October 4, 2014
Serum resistin levels in children with primary snoringA M Zicari, R Cutrera, F Occasi, et al.
Cancer|January 26, 2011
Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45Hua Li, Yasushi Adachi, Hiroyuki Yamamoto, et al.
The Oncologist|November 10, 2009
Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapyLuigi Moretti, David S Yu, Heidi Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancerRobert Mutter, Bo Lu, David P Carbone, et al.
Pageof 66

Showing results (461-470 of 651) with videos related to

Sort By:
Pageof 66
Cancer Research Communications|October 18, 2023
Exogenous Sequences in Tumors and Immune Cells (Exotic): A Tool for Estimating the Microbe Abundances in Tumor RNA-seq DataRebecca Hoyd, Caroline E Wheeler, YunZhou Liu, et al.
The Journal of Clinical Investigation|March 6, 2003
Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptorLi Yang, Noboru Yamagata, Rajwardhan Yadav, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Phase I study of Paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced non-small cell lung cancerDavid I Rosenthal, Clifton David Fuller, Mitchell Machtay, et al.
The Journal of Clinical Investigation|December 18, 2025
PPP2R2A insufficiency enhances PD-L1 immune checkpoint blockade efficacy in lung cancer through cGAS-STING activationZhaojun Qiu, No-Joon Song, Anqi Li, et al.
Annals of Internal Medicine|May 1, 1980
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer InstituteV T DeVita, R M Simon, S M Hubbard, et al.
JTO Clinical and Research Reports|April 18, 2025
Trends in Mesothelioma Mortality in the United States Between 1999 and 2020Alexander J Didier, Mingjia Li, Jinesh Gheeya, et al.
International Journal of Immunopathology and Pharmacology|October 4, 2014
Serum resistin levels in children with primary snoringA M Zicari, R Cutrera, F Occasi, et al.
Cancer|January 26, 2011
Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45Hua Li, Yasushi Adachi, Hiroyuki Yamamoto, et al.
The Oncologist|November 10, 2009
Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapyLuigi Moretti, David S Yu, Heidi Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancerRobert Mutter, Bo Lu, David P Carbone, et al.
Pageof 66